125 related articles for article (PubMed ID: 4929814)
1. The minimal inhibitory concentrations of sulphadimethozine and sulphadoxine against Mycobacterium leprae.
Ellard GA; Gammon PT; Rees RJ
Lepr Rev; 1970 Oct; 41(4):223-8. PubMed ID: 4929814
[No Abstract] [Full Text] [Related]
2. Drug resistance of Mycobacterium leprae, particularly to DDS.
Rees RJ
Int J Lepr Other Mycobact Dis; 1967; 35(4):625-38. PubMed ID: 4173566
[No Abstract] [Full Text] [Related]
3. Sequential blockade of the mycobacterial de novo folate pathway. A review.
Morrison NE
Int J Lepr Other Mycobact Dis; 1971; 39(1):34-43. PubMed ID: 4399473
[No Abstract] [Full Text] [Related]
4. Minimal inhibitory concentration of dapsone for Mycobacterium leprae in rats.
Peters JH; Gordon GR; Murray JF; Fieldsteel AH; Levy L
Antimicrob Agents Chemother; 1975 Nov; 8(5):551-7. PubMed ID: 1108776
[TBL] [Abstract][Full Text] [Related]
5. Some characteristics of the action of dapsone on multiplication of Mycobacterium leprae in the mouse.
Levy L; Peters JH
Lepr Rev; 1977 Dec; 48(4):237-45. PubMed ID: 400808
[No Abstract] [Full Text] [Related]
6. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
Shepard CC; Levy L; Fasal P
Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
[No Abstract] [Full Text] [Related]
7. Mode of action of sulphones.
Bergel M
Nihon Rai Gakkai Zasshi; 1984; 53(4):214-5. PubMed ID: 6399286
[No Abstract] [Full Text] [Related]
8. Studies on dapsone-resistant Mycobacterium leprae in leprosy patients of Gudiyatham Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 2. A progress report.
Almeida JG; Christian M; Chacko CJ; Taylor PM; Fritschi EP
Lepr Rev; 1983 Sep; 54(3):185-91. PubMed ID: 6355722
[No Abstract] [Full Text] [Related]
9. The effect of rifampicin and dapsone on experimental Mycobacterium leprae infections: minimum inhibitory concentrations and bactericidal action.
Holmes IB; Hilson GR
J Med Microbiol; 1972 May; 5(2):251-61. PubMed ID: 4555734
[No Abstract] [Full Text] [Related]
10. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses.
Browne SG
Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048
[No Abstract] [Full Text] [Related]
11. Experimental chemotherapy in leprosy, then and now.
Shepard CC
Int J Lepr Other Mycobact Dis; 1973; 41(3):307-19. PubMed ID: 4136732
[No Abstract] [Full Text] [Related]
12. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411
[No Abstract] [Full Text] [Related]
13. Correlation of laboratory and clinical data during treatment of leprosy.
Pattyn SR; Rollier R; Rollier MR; De Muynck A; Janssens PG; Verdoolaeghe-Van Loo G
Ann Soc Belg Med Trop; 1972; 52(6):537-48. PubMed ID: 4574223
[No Abstract] [Full Text] [Related]
14. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy.
Balakrishnan S; Seshadri PS; Neelan PN; Venkataramaniah HN; Harikrishnan S; Bhatia VN
Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413
[TBL] [Abstract][Full Text] [Related]
15. [Dapsone inhibition of the bactericidal action of rifampicin on Mycobacterium leprae in mice].
Millan J; Moulia-Pelat JP
Med Trop (Mars); 1989; 49(4):337-41. PubMed ID: 2695734
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo activity of K-130, a dihydrofolate reductase inhibitor, against Mycobacterium leprae.
Dhople AM
Arzneimittelforschung; 1999 Mar; 49(3):267-71. PubMed ID: 10219472
[TBL] [Abstract][Full Text] [Related]
17. Dapsone-resistant leprosy in Jakarta: a preliminary report.
Utji R; Kosasih A; Santoso AU
Lepr Rev; 1983 Sep; 54(3):193-5. PubMed ID: 6355723
[No Abstract] [Full Text] [Related]
18. Sensitivity of Mycobacterium leprae to low levels of 4,4'-diaminodiphenyl sulfone.
Shepard CC; McRae DH; Habas JA
Proc Soc Exp Biol Med; 1966 Jul; 122(3):893-6. PubMed ID: 5331452
[No Abstract] [Full Text] [Related]
19. Prevalence of secondary dapsone-resistant leprosy in Upper Volta.
Pattyn SR; Yada A; Sansarricq H; van Loo L
Lepr Rev; 1984 Dec; 55(4):361-7. PubMed ID: 6396476
[No Abstract] [Full Text] [Related]
20. In vitro and in vivo experiments with the new inhibitor of mycobacterium leprae brodimoprim alone and in combination with dapsone.
Seydel JK; Wempe EG; Rosenfeld M; Jagannathan R; Mahadevan PR; Dhople AM
Arzneimittelforschung; 1990 Jan; 40(1):69-75. PubMed ID: 2187440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
